Spanish Flag


A Digital Guardian Angel Enhancing Cancer Patient’s Wellbeing and Health Status Improvement Following Treatment

Call H2020-SC1-DTH-2018-2020
Topic SC1-DTH-11-2019: “Big data and Artificial Intelligence for monitoring health status and quality of life after the cancer treatment
Type IA
Reference Grant Agreement No. 875392
Duration Gennaio 2020 – December 2022 (36 months)
Budget € 4.872.250,00
Funding € 4.872.250,00

Project Summary

The burden of cancer is rising globally and is estimated to have reached 18.1 million new cases and 9.6 million cancer deaths in 2018. Despite the rising cancer incidence, improvements in early detection and therapeutic treatment have improved cancer survival. As a consequence, the number of cancer survivors is increasing globally, creating the need to improve not only treatment but also wellness and follow‐up care. Cancer treatment often involves combined modalities such as surgery, chemotherapy, and radiotherapy. In the past decades, more effective and targeted therapeutic modalities and less destructive cancer treatments have been developed such as immunotherapy and drug‐targeted therapy. Even so, cancer and its treatment have important physical and psychosocial sequelae.

ONCORELIEF will leverage the above 6 drivers in order to skillfully and methodologically overcome technical challenges, by introducing new approaches that will allow the utilization of big datasets in order to develop a user-centered AI System to facilitate the integration of QoL assessment instruments through the use of PROMs and PREMs in order to improve post-treatment health status, increase the wellbeing, and follow‐up care of cancer patients. This will be achieved through an intuitive smart digital assistant (Guardian Angel), able to provide personalized support in post-treatment activities and tasks, suggest actions regarding the patients’ overall health-status, improved wellbeing and active health-care and ultimately maintain him/her engaged on a wellness journey that will safeguard his/her health over the foreseeable prolonged post-cancer treatment period.

The role of Maggioli can be summarized as follows:

  • Technical Coordinator
  • System Integrator
  • Technological Provider



  • Exus Software Ltd. (UK)
  • Maggioli S.p.A. (Italy)
  • InnoSystems IKE (Greece)
  • CareAcross Ltd. (UK)
  • Centre for Research & Technology Hellas (Greece)
  • Suite5 Data Intelligence Solutions (Cyprus)
  • MCS Datalabs GmbH (Germany)
  • Fraunhofer ITWM (Germany)
  • University Medical Center Mainz (Germany)
  • Alma Mater Studiorum Università di Bologna (Italy)
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (Italy)
  • Schön Klinik Bad Aibling (Portugal)
  • Time.Lex (Belgium)

About aduzha

© Maggioli Group
All rights reserved. Maggioli Spa
P.VAT 02066400405